nor-binaltorphimine (Avekshan)

N/A

Report date: 2025/03/20 14:42:33
NME

Base Information

Drug Namenor-binaltorphimine (Avekshan)
Drug Alias NameNorbinalnor-binaltorphiminenor-BNI (Avekshan)nor-BNI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor antagonists
TargetsKappa opioid receptor
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvekshan Llc
China Registration ClassN/A

Develop Information

Active CompaniesAvekshan Llc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A